David Dawson Cosgrove

David Dawson Cosgrove (born April 1960) is an Irish businessman whose Belvedere Management group claimed to have $16 billion of assets under administration. In 2016 he was barred from serving as an officer of any company regulated by the Mauritius Financial Services Commission (FSC) for a period of 5 years and the funds he managed were liquidated. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'David Cosgrove', query time: 0.03s Refine Results
  1. 1
    Enhancement patterns of gastric carcinoma on contrast-enhanced ultrasonography: relationship with clinicopathological features.

    Enhancement patterns of gastric carcinoma on contrast-enhanced ultrasonography: relationship with clinicopathological features. by Fang Wei, Pintong Huang, Shiyan Li, Jian Chen, Ying Zhang, Yurong Hong, Shumei Wei, David Cosgrove

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management

    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management by Kelly J. Lafaro, David Cosgrove, Jean-Francois H. Geschwind, Ihab Kamel, Joseph M. Herman, Timothy M. Pawlik

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.

    Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma. by Aaron T Wild, Nishant Gandhi, Sivarajan T Chettiar, Khaled Aziz, Rajendra P Gajula, Russell D Williams, Rachit Kumar, Kekoa Taparra, Jing Zeng, Jessica A Cades, Esteban Velarde, Siddharth Menon, Jean F Geschwind, David Cosgrove, Timothy M Pawlik, Anirban Maitra, John Wong, Russell K Hales, Michael S Torbenson, Joseph M Herman, Phuoc T Tran

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyResearch in context

    Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 studyResear... by Marwan Fakih, Kanwal Pratap Singh Raghav, David Z. Chang, Tim Larson, Allen L. Cohn, Timothy K. Huyck, David Cosgrove, Joseph A. Fiorillo, Rachel Tam, David D'Adamo, Neelesh Sharma, Barbara J. Brennan, Ying A. Wang, Sabine Coppieters, Hong Zebger-Gong, Anke Weispfenning, Henrik Seidel, Bart A. Ploeger, Udo Mueller, Carolina Soares Viana de Oliveira, Andrew Scott Paulson

    Published 2023-04-01
    Get full text
    Article
  5. 5
    How to perform Contrast-Enhanced Ultrasound (CEUS)

    How to perform Contrast-Enhanced Ultrasound (CEUS) by Christoph F. Dietrich, Michalakis Averkiou, Michael Bachmann Nielsen, Richard G. Barr, Peter N. Burns, Fabrizio Calliada, Vito Cantisani, Byung Choi, Maria C. Chammas, Dirk-André Clevert, Michel Claudon, Jean-Michel Correas, Xin-Wu Cui, David Cosgrove, Mirko D'Onofrio, Yi Dong, JohnR. Eisenbrey, Teresa Fontanilla, Odd Helge Gilja, Andre Ignee, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Nathalie Lassau, Andrej Lyshchik, Maria Franca Meloni, Fuminori Moriyasu, Christian Nolsøe, Fabio Piscaglia, Maija Radzina, Adrian Saftoiu, Paul S. Sidhu, Ioan Sporea, Dagmar Schreiber-Dietrich, Claude B. Sirlin, Maria Stanczak, Hans-Peter Weskott, Stephanie R. Wilson, Juergen Karl Willmann, Tae Kyoung Kim, Hyun-Jung Jang, Alexandar Vezeridis, Sue Westerway

    Published 2018-01-01
    Get full text
    Article

Search Tools: